- Overview
- Dividends
- Performance
- Calculators
- Rolling Returns
- Drawdowns
Overview
| Dividend | 7.38 |
| Ex-Dividend Date | Dec 08, 2023 |
| Annualized Return (1Y) | -519,889.21% |
| Volume | 100 |
| Close | 32.01 |
| Previous Close | 31.88 |
| Inception Date | Jan 04, 2022 |
Dividends
Kelly CRISPR & Gene Editing Technology ETF (XDNA) Dividend Information
Kelly CRISPR & Gene Editing Technology ETF (XDNA) dividend growth in the last 12 months is 79304.30%
The trailing 12-month yield of Kelly CRISPR & Gene Editing Technology ETF is 74.74%. Its dividend history:
| Pay Date | Cash Amount |
|---|---|
| Dec 08, 2023 | $7.3846 |
| Dec 22, 2022 | $0.0093 |
Kelly CRISPR & Gene Editing Technology ETF (XDNA) Dividend Calculator
Dividend Growth History for Kelly CRISPR & Gene Editing Technology ETF (XDNA)
|
Year
|
Payout Amount
|
Year Start Yield
|
Annual Payout Growth (YoY)
|
CAGR to 2023
|
|---|---|---|---|---|
| 2023 | $7.3846 | 74.74% | 79,304.30% | - |
| 2022 | $0.0093 | 0.06% | - | 79,304.30% |
Dividend Growth Chart for Kelly CRISPR & Gene Editing Technology ETF (XDNA)
Performance
Kelly CRISPR & Gene Editing Technology ETF (XDNA) Historical Returns And Risk Info
From 01/04/2022 to 01/03/2024, the compound annualized total return (dividend reinvested) of Kelly CRISPR & Gene Editing Technology ETF (XDNA) is //">//'>//">//'>. Its cumulative total return (dividend reinvested) is .
From 01/04/2022 to 01/03/2024, the Maximum Drawdown of Kelly CRISPR & Gene Editing Technology ETF (XDNA) is 342783.0%.
From 01/04/2022 to 01/03/2024, the Sharpe Ratio of Kelly CRISPR & Gene Editing Technology ETF (XDNA) is 0.37.
From 01/04/2022 to 01/03/2024, the Annualized Standard Deviation of Kelly CRISPR & Gene Editing Technology ETF (XDNA) is 111.8%.
From 01/04/2022 to 01/03/2024, the Beta of Kelly CRISPR & Gene Editing Technology ETF (XDNA) is -85.03.
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| XDNA (Kelly CRISPR & Gene Editing Technology ETF) | NA | -519,889.21% | NA | NA | NA | NA | NA | ... | ... |
| VTSMX (VANGUARD TOTAL STOCK MARKET INDEX FUND INVESTOR SHARES) | NA | 24.34% | 8.26% | 15.09% | 11.22% | 13.40% | 9.53% | ... | ... |
| Ticker/Portfolio | Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | XDNA (Kelly C...logy ETF) | 0.41 | -519,889.21 | NA | NA | NA | NA | NA | ... | ... | NA | NA | 0.41 | -514,653.41 | -33.73 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| VTSMX (VANGUA...R SHARES) | -2.01 | 24.34 | 8.26 | 15.09 | 11.22 | 13.40 | 9.53 | ... | ... | NA | 17.01 | 23.61 | 25.87 | -19.60 | 25.59 | 20.87 | 30.63 | -5.27 | 21.05 | 12.54 | 0.28 | 12.43 | 33.34 | 16.25 | 0.97 | 17.09 | 28.68 | -37.04 | 5.49 | 15.51 | 5.98 | 13.24 | 31.90 | -20.97 | -10.98 | -9.31 | 27.17 | 24.93 | 32.62 | 21.28 | 34.97 | -0.44 | 11.29 | 10.52 | |
| Sharpe Ratio | XDNA (Kelly C...logy ETF) | NA | 1.26 | NA | NA | NA | NA | NA | ... | ... | NA | NA | NA | 1.46 | -0.69 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| VTSMX (VANGUA...R SHARES) | NA | 1.84 | 1.18 | 0.55 | 0.70 | NA | NA | ... | ... | 1.33 | 0.75 | 1.54 | 1.65 | -0.85 | 1.86 | 0.58 | 2.30 | -0.39 | 2.90 | 0.91 | 0.02 | 1.06 | 2.93 | 1.24 | 0.04 | 0.91 | 1.02 | -0.92 | 0.15 | 1.14 | 0.35 | 1.07 | 1.90 | -0.89 | -0.61 | -0.56 | 1.38 | 1.10 | 1.80 | 1.60 | 4.16 | -0.38 | 1.09 | 1.61 | |
| Standard Deviation(%) | XDNA (Kelly C...logy ETF) | NA | 147.76 | NA | NA | NA | NA | NA | ... | ... | NA | NA | 0.00 | 150.57 | 51.69 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| VTSMX (VANGUA...R SHARES) | NA | 12.54 | 15.18 | 17.38 | 18.48 | NA | NA | ... | ... | 14.26 | 18.94 | 12.98 | 13.58 | 24.93 | 13.73 | 35.12 | 12.67 | 16.95 | 7.05 | 13.58 | 15.32 | 11.75 | 11.35 | 13.13 | 24.46 | 18.73 | 28.06 | 41.10 | 16.06 | 10.63 | 10.61 | 11.42 | 16.43 | 24.84 | 22.29 | 23.98 | 17.19 | 19.58 | 16.03 | 10.95 | 7.45 | 9.26 | 8.33 | 8.35 | |
| Draw Down(%) | XDNA (Kelly C...logy ETF) | NA | 436,793.66 | NA | NA | NA | NA | NA | ... | ... | NA | NA | 0.00 | 435,020.14 | 41.97 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| VTSMX (VANGUA...R SHARES) | NA | 8.93 | 19.37 | 25.43 | 34.98 | NA | NA | ... | ... | 8.93 | 19.37 | 8.56 | 10.77 | 25.43 | 5.22 | 34.98 | 6.78 | 20.19 | 2.77 | 11.32 | 12.11 | 7.57 | 5.71 | 10.01 | 20.42 | 16.25 | 27.37 | 48.39 | 10.00 | 8.46 | 6.95 | 7.92 | 13.23 | 32.50 | 29.46 | 20.20 | 11.47 | 21.99 | 10.11 | 9.38 | 2.68 | 8.23 | 5.04 | 4.86 | |
| Yield(%) | XDNA (Kelly C...logy ETF) | 0.00 | 74.74 | 16.43 | 9.86 | 4.93 | 3.29 | 2.46 | ... | ... | NA | NA | 0.00 | 74.74 | 0.06 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| VTSMX (VANGUA...R SHARES) | 0.00 | 1.19 | 1.60 | 1.45 | 2.60 | 3.62 | 3.33 | ... | ... | 0.28 | 1.18 | 1.43 | 1.67 | 1.21 | 1.39 | 1.57 | 2.15 | 1.77 | 1.90 | 2.05 | 1.84 | 1.84 | 2.09 | 2.27 | 1.76 | 1.90 | 2.29 | 1.68 | 1.77 | 1.72 | 1.66 | 2.37 | 2.10 | 1.13 | 1.05 | 2.80 | 5.29 | 3.57 | 4.85 | 2.99 | 2.46 | 2.32 | 3.32 | 2.30 |
Return Calculator for Kelly CRISPR & Gene Editing Technology ETF (XDNA)
Start date (MM/dd/yyyy)
End date (MM/dd/yyyy)
Kelly CRISPR & Gene Editing Technology ETF (XDNA) Historical Return Chart
Calculators
Dollar Cost Average Calculator for Kelly CRISPR & Gene Editing Technology ETF (XDNA)
Retirement Spending Calculator for Kelly CRISPR & Gene Editing Technology ETF (XDNA)
Rolling Returns
A rolling return for a period such as 5-year, as of a specific date, represents the investment’s performance over the preceding five years leading up to that date. In the 5-year rolling chart, the value on any given date corresponds to the annualized return for the preceding 5 years up to that very date. Thus, for instance, the chart value on 8/28/2015 reflects the annualized return from 8/28/2010 to 8/28/2015. A 5-year rolling return chart for an investment (stock, fund or portfolio) depicts the return sequence of 5-year trailing returns for the dates in the chart.
These rolling returns contrast with the most recent 3, 5, 10, and 15-year returns, as they solely depict the returns for those respective periods leading up to the most recent date, without encompassing every date in the historical record.
Rolling return charts offer a more precise insight into a portfolio’s risk and return stability (including funds or individual stocks). This is particularly true when focusing on the minimal return points within a rolling return chart as a measure of a fund or a portfolio's risk. A well-known observation, often attributed to ‘Murphy’s law’, is that it tends to perform poorly when investors decide to follow an investment due to its recent strong returns. Sound familiar? Information regarding minimum rolling returns could help mitigate this predicament. Investors can opt for an investment showcasing high minimum rolling returns within their preferred holding durations. In fact, merely possessing knowledge of such minimum rolling period returns can anchor investors’ expectations.
For instance, let’s consider an investor who follows a model portfolio (or even simply purchases and holds a fund like VFINX or SPY) for 10 years. Armed with knowledge of this portfolio’s minimum 10-year rolling return since its inception date or the fund’s inception (in the case of VFINX, recognizing that the minimum 10-year rolling return since 1987 could be as low as -2.24%), the investor should reasonably anticipate the potential for the portfolio to incur losses over the forthcoming 10 years.
Minimum rolling return for a period such as 10-year offers a different and often better historical risk and return metric than other popular risk and return metrics such as Sharpe ratio, standard deviation (volatility) or maximum drawdown.
See Portfolio Calculator and Rolling Returns for more detailed description.
Drawdowns
Kelly CRISPR & Gene Editing Technology ETF (XDNA) Maximum Drawdown
Related Articles for Kelly CRISPR & Gene Editing Technology ETF(XDNA)
